The “plausibility” threshold remains low in Australia
The requirement that a patent specification sufficiently enables the subject matter of the claims is particularly relevant to pharmaceutical inventions and can be a hurdle for innovators even if...
The requirement that a patent specification sufficiently enables the subject matter of the claims is particularly relevant to pharmaceutical...
Read More
Claim Drafting Tip: Written Description and Obviousness of Claims with Functional Features — Two Sides of the Same Coin
A recent precedential decision by the United States Federal Circuit (Nuvo Pharmaceuticals v DR. Reddy’s Laboratories (Fed Cir, No 17-2473, 15 May 2019) has provided valuable advice on the balance between...
A recent precedential decision by the United States Federal Circuit (Nuvo Pharmaceuticals v DR. Reddy’s Laboratories (Fed Cir, No 17-2473,...
Read More
Pharmaceutical patents: Fighting a $25 million claim for damages
A recent Full Federal Court decision in Australia provides a useful insight as to how a Court in Australia will calculate damages in proceedings concerning the infringement of a...
A recent Full Federal Court decision in Australia provides a useful insight as to how a Court in Australia...
Read More
New Zealand Update: ACTIPHEN Too Similar to ACTAZIN to Register
Anagenix opposed the Pharmazen’s application to register ACTIPHEN in connection with a range of medicinal food preparations (Class 5) and printed materials relating to those goods (Class 16).
Anagenix opposed the Pharmazen’s application to register ACTIPHEN in connection with a range of medicinal food preparations (Class 5)...
Read More
Case Note: H Lundbeck A/S & Anor v Sandoz Pty Ltd
A recent decision of the Federal Court of Australia has demonstrated that the launch of a pharmaceutical product by a generic company even after expiry of the standard term...
A recent decision of the Federal Court of Australia has demonstrated that the launch of a pharmaceutical product by...
Read More
Sigma Pharmaceuticals Case Clarifies Aspects of Compensable Loss
The recent decision in Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth FCA 1556 has clarified, among other things, a number of issues concerning compensation arising from the usual...
The recent decision in Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth FCA 1556 has clarified, among other things,...
Read More